Balance Sheet
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInventory AverageInvested Capital

Ascendis Pharma A (ASND) Equity Ratio (2016 - 2025)

Ascendis Pharma A's Equity Ratio history spans 7 years, with the latest figure at 0.18 for Q4 2023.

  • For Q4 2023, Equity Ratio fell 173.03% year-over-year to 0.18; the TTM value through Dec 2023 reached 0.18, down 173.03%, while the annual FY2023 figure was 0.18, 173.03% down from the prior year.
  • Equity Ratio for Q4 2023 was 0.18 at Ascendis Pharma A, down from 0.24 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.88 in Q4 2019 and bottomed at 0.18 in Q4 2023.
  • The 4-year median for Equity Ratio is 0.53 (2022), against an average of 0.44.
  • The largest annual shift saw Equity Ratio rose 0.5% in 2019 before it crashed 173.03% in 2023.
  • A 4-year view of Equity Ratio shows it stood at 0.88 in 2019, then fell by 7.69% to 0.81 in 2021, then crashed by 70.33% to 0.24 in 2022, then tumbled by 173.03% to 0.18 in 2023.
  • Per Business Quant, the three most recent readings for ASND's Equity Ratio are 0.18 (Q4 2023), 0.24 (Q4 2022), and 0.81 (Q4 2021).